R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial

Martine E.D. Chamuleau, Frank Stenner, Dana Chiţu, Urban Novak, Monique C. Minnema, Paul A. F. Geerts, Wendy B.C. Stevens, Thorsten Zenz, Gustaaf W. van Imhoff, Ka Lung Wu, A. M. P. Demandt, Marie José Kersten, Wim Terpstra, Lidwine W. Tick, Dries Deeren, Éric Van Den Neste, Michael Gregor, Hendrik Veelken, Lara H. Böhmer, Clemens B. Caspar, Pim Mutsaers, Jeannine Refos, Robby Sewsaran, Liping Fu, Rianne Seefat, Carin A. Uyl‐de Groot, Stefan Dirnhofer, Michiel van den Brand, Daphne de Jong, Marcel Nijland, Pieternella J. Lugtenburg